DK135775C - - Google Patents

Info

Publication number: DK135775C
Authority: DK; Denmark

Application number

DK260473A

Other languages

Danish (da)

Other versions

DK135775B (da

Inventor

G H Phillipps

R Lawrence

L Stephenson

B E Ayres

Original Assignee

Glaxo Laboratories Ltd

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1972-05-12

Filing date

1973-05-11

Publication date

1977-11-21

1973-05-11 Application filed by Glaxo Laboratories Ltd filed Critical Glaxo Laboratories Ltd

1977-06-20 Publication of DK135775B publication Critical patent/DK135775B/da

1977-11-21 Application granted granted Critical

1977-11-21 Publication of DK135775C publication Critical patent/DK135775C/da

Links

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J43/00—Normal steroids having a nitrogen-containing hetero ring spiro-condensed or not condensed with the cyclopenta(a)hydrophenanthrene skeleton
- C07J43/003—Normal steroids having a nitrogen-containing hetero ring spiro-condensed or not condensed with the cyclopenta(a)hydrophenanthrene skeleton not condensed

Landscapes

Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Health & Medical Sciences (AREA)
General Health & Medical Sciences (AREA)
Steroid Compounds (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

DK260473AA 1972-05-12 1973-05-11 Analogifremgangsmåde til fremstilling af mættede 3alfa-hydroxy-5alfa-pregnaner. DK135775B (da)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
GB2248972A GB1436324A (en)	1972-05-12	1972-05-12	Anaesthetic 3alpha-hydroxy pregnanes

Publications (2)

Publication Number	Publication Date
DK135775B DK135775B (da)	1977-06-20
DK135775C true DK135775C (fr)	1977-11-21

Family

ID=10180241

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
DK260473AA DK135775B (da)	1972-05-12	1973-05-11	Analogifremgangsmåde til fremstilling af mættede 3alfa-hydroxy-5alfa-pregnaner.

Country Status (13)

Country	Link
US (1)	US3998829A (fr)
JP (1)	JPS4948652A (fr)
AU (1)	AU474687B2 (fr)
BE (1)	BE799433A (fr)
CA (1)	CA1014947A (fr)
DE (1)	DE2323950A1 (fr)
DK (1)	DK135775B (fr)
FR (1)	FR2184711B1 (fr)
GB (1)	GB1436324A (fr)
IE (1)	IE38863B1 (fr)
LU (1)	LU67585A1 (fr)
NL (1)	NL7306606A (fr)
ZA (1)	ZA733218B (fr)

Families Citing this family (27)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US4613463A (en) *	1984-11-01	1986-09-23	The Upjohn Company	Process and intermediates for the preparation of 17 alphahydroxyprogesterones and corticoids from an enol steroid
US5380840A (en) *	1985-09-12	1995-01-10	The Upjohn Company	Triazinylpiperazinyl steroids
USRE35053E (en) *	1985-09-12	1995-10-10	The Upjohn Company	Amines useful in producing pharmaceutically active CNS compounds
US5099019A (en) *	1985-09-12	1992-03-24	Upjohn Company	Amines useful in producing pharmaceutically active CNS compounds
US5232917A (en) *	1987-08-25	1993-08-03	University Of Southern California	Methods, compositions, and compounds for allosteric modulation of the GABA receptor by members of the androstane and pregnane series
JPH072555Y2 (ja) *	1991-06-03	1995-01-25	日野自動車工業株式会社	車輛の前後方向兼用ウインチ
US6780853B1 (en)	1995-06-06	2004-08-24	Euro-Celtique S.A.	Neuroactive steroids of the androstane and pregnane series
RU2194712C2 (ru) *	1995-06-06	2002-12-20	Коукенсис, Инк.	НЕЙРОАКТИВНЫЕ СТЕРОИДЫ, ФАРМАЦЕВТИЧЕСКИЙ ПРЕПАРАТ, СПОСОБ ЛЕЧЕНИЯ ИЛИ ПРОФИЛАКТИКИ РАЗЛИЧНЫХ НАРУШЕНИЙ, СПОСОБ ИНДУКЦИИ СНА И СПОСОБ ИНДУКЦИИ АНЕСТЕЗИИ С ИХ ИСПОЛЬЗОВАНИЕМ, СПОСОБ МОДУЛИРОВАНИЯ КОМПЛЕКСА РЕЦЕПТОР ГАМКa-ХЛОРИДНЫЙ ИОНОФОР
US6143737A (en) *	1995-06-23	2000-11-07	Georgetown University	Progesterone analogs to reverse multidrug resistance
UA73736C2 (en) *	1999-04-29	2005-09-15	Euro Celtic S A	Method for alleviating or preventing insomnia and inducing anesthesia
US20050101581A1 (en) *	2002-08-28	2005-05-12	Reading Christopher L.	Therapeutic treatment methods 2
CN119192266A (zh)	2011-10-14	2024-12-27	萨奇治疗股份有限公司	3,3-二取代的19-去甲孕甾烷化合物、组合物、及其用途
WO2014169831A1 (fr)	2013-04-17	2014-10-23	Sage Therapeutics, Inc.	19-nor-hétéroaryl-stéroïdes c21-c-liés c3,3-disubstitués et procédés d'utilisation de ceux-ci
JP6470258B2 (ja)	2013-04-17	2019-02-13	セージセラピューティクス，インコーポレイテッド	１９−ノルｃ３，３−ジ置換ｃ２１−ｎ−ピラゾリルステロイドおよびその使用方法
WO2014169836A1 (fr)	2013-04-17	2014-10-23	Sage Therapeutics, Inc.	19-nor-stéroïdes neuroactifs et procédés d'utilisation de ceux-ci
ES2807264T3 (es)	2013-04-17	2021-02-22	Sage Therapeutics Inc	Esteroides neuroactivos 19-nor para métodos de tratamiento
WO2015010054A2 (fr)	2013-07-19	2015-01-22	Sage Therapeutics, Inc.	Stéroïdes neuroactifs, compositions, et leurs utilisations
ES2848823T3 (es)	2013-08-23	2021-08-12	Sage Therapeutics Inc	Esteroides neuroactivos, composiciones y usos de los mismos
WO2015195962A1 (fr)	2014-06-18	2015-12-23	Sage Therapeutics, Inc.	Stéroïdes neuroactifs, leurs compositions et utilisations
ME03809B (fr)	2014-10-16	2021-04-20	Sage Therapeutics Inc	Compositions et méthodes pour traiter des troubles du snc
US10577390B2 (en) *	2014-10-16	2020-03-03	Sage Therapeutics, Inc.	Compositions and methods for treating CNS disorders
WO2016082789A1 (fr) *	2014-11-27	2016-06-02	Sage Therapeutics, Inc.	Compositions et procédés pour traiter des troubles du snc
WO2016123056A1 (fr)	2015-01-26	2016-08-04	Sage Therapeutics, Inc.	Compositions et méthodes pour le traitement des troubles du snc
EP4155314A1 (fr)	2015-02-20	2023-03-29	Sage Therapeutics, Inc.	Stéroïdes neuroactifs, compositions et leurs utilisations
MA45599A (fr)	2016-07-11	2019-05-15	Sage Therapeutics Inc	Stéroïdes neuroactifs substitués en c17, c20 et c21 et leurs procédés d'utilisation
US20190233465A1 (en)	2016-07-11	2019-08-01	Sage Therapeutics, Inc.	C7, c12, and c16 substituted neuroactive steroids and their methods of use
CR20240234A (es)	2019-05-31	2024-07-09	Sage Therapeutics Inc	ESTEROIDES NEUROACTIVOS Y COMPOSICIONES DE ESTOS (Divisional 2021-629)

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
DE1107662B (de) *	1959-07-04	1961-05-31	Merck Ag E	Verfahren zur Herstellung von Mannichbasen von Steroiden bzw. von deren Saeureadditionssalzen
US3042691A (en) *	1960-05-11	1962-07-03	Pfizer & Co C	5alpha,21-dibromo-6beta-fluoro-21-methyl-pregnanes and process for making same
FR1764M (fr) *	1962-02-20	1963-04-08	Roussel Uclaf	Nouveau médicament notamment pour le traitement des spasmes d'origine coronarienne ou viscérale.
US3201425A (en) *	1963-12-10	1965-08-17	American Cyanamid Co	20-alkoxy-delta20-21-carboxaldehydes of the pregnane series and method of preparing the same
GB1089945A (en) *	1965-09-23	1967-11-08	British Drug Houses Ltd	Steroidal-6-spirocyclopropyl-4-en-3-ones
GB1317184A (en) *	1969-06-20	1973-05-16	Glaxo Lab Ltd	Steroid-containing pharmaceutical preparations
DE1941226A1 (de) *	1969-08-13	1971-02-18	Degussa	Basisch substituierte Ketosteroide
US3661940A (en) *	1970-04-13	1972-05-09	Sandoz Ag	Derivatives of 21-methyl-19-norpregnanes
GB1377609A (en) *	1970-12-17	1974-12-18	Glaxo Lab Ltd	3alpha-hydroxy-5alpha-pregnane compounds
GB1416427A (en) *	1972-01-12	1975-12-03	Akzo Nv	Alkylated pregnanes and process for obtaining same

1972
- 1972-05-12 GB GB2248972A patent/GB1436324A/en not_active Expired
1973
- 1973-05-08 US US05/358,381 patent/US3998829A/en not_active Expired - Lifetime
- 1973-05-11 CA CA171,026A patent/CA1014947A/en not_active Expired
- 1973-05-11 DE DE2323950A patent/DE2323950A1/de not_active Ceased
- 1973-05-11 AU AU55616/73A patent/AU474687B2/en not_active Expired
- 1973-05-11 IE IE00753/73A patent/IE38863B1/xx unknown
- 1973-05-11 FR FR7317079A patent/FR2184711B1/fr not_active Expired
- 1973-05-11 ZA ZA733218A patent/ZA733218B/xx unknown
- 1973-05-11 NL NL7306606A patent/NL7306606A/xx not_active Application Discontinuation
- 1973-05-11 JP JP48052424A patent/JPS4948652A/ja active Pending
- 1973-05-11 DK DK260473AA patent/DK135775B/da unknown
- 1973-05-11 BE BE131031A patent/BE799433A/fr unknown
- 1973-05-11 LU LU67585A patent/LU67585A1/xx unknown

Also Published As

Publication number	Publication date
BE799433A (fr)	1973-11-12
LU67585A1 (fr)	1973-07-24
AU5561673A (en)	1974-11-14
ZA733218B (en)	1974-05-29
DE2323950A1 (de)	1973-12-13
GB1436324A (en)	1976-05-19
US3998829A (en)	1976-12-21
IE38863B1 (en)	1978-06-21
JPS4948652A (fr)	1974-05-11
FR2184711A1 (fr)	1973-12-28
IE38863L (en)	1973-11-12
NL7306606A (fr)	1973-11-14
DK135775B (da)	1977-06-20
CA1014947A (en)	1977-08-02
AU474687B2 (en)	1976-07-29
FR2184711B1 (fr)	1977-01-07

Publication	Publication Date	Title
FR2184711B1 (fr)	1977-01-07
JPS49101111A (fr)	1974-09-25
CS163292B2 (fr)	1975-08-29
CS162957B1 (fr)	1975-07-31
JPS4879874A (fr)	1973-10-26
FR2195423A1 (fr)	1974-03-08
JPS5130578B2 (fr)	1976-09-01
JPS5330284B2 (fr)	1978-08-25
JPS4946192A (fr)	1974-05-02
FR2193061A1 (fr)	1974-02-15
JPS492291A (fr)	1974-01-10
JPS4936149A (fr)	1974-04-03
JPS55734B2 (fr)	1980-01-09
JPS48102524A (fr)	1973-12-22
JPS4920541A (fr)	1974-02-23
JPS4922147A (fr)	1974-02-27
JPS4982448A (fr)	1974-08-08
JPS5516216Y2 (fr)	1980-04-15
JPS5124287Y2 (fr)	1976-06-22
JPS5615864Y2 (fr)	1981-04-14
CS165504B1 (fr)	1975-12-22
CS159124B1 (fr)	1974-12-27
CS154505B1 (fr)	1974-04-30
CS155590B1 (fr)	1974-05-30
JPS4982297U (fr)	1974-07-17